background
object
communitybas
elderli
studi
concern
microbiolog
acut
respiratori
infect
scarc
data
subclin
infect
even
total
absent
although
asymptomat
person
might
act
sourc
respiratori
infect
method
communitybas
studi
prospect
investig
possibl
virolog
caus
acut
respiratori
infect
symptomat
case
episod
symptomfre
control
period
particip
person
year
report
daili
presenc
respiratori
symptom
diari
virolog
assess
perform
polymeras
chain
reaction
pcr
serolog
result
case
episod
pathogen
demonstr
common
rhinovirus
coronavirus
influenzavirus
odd
ratio
demonstr
viru
case
symptom
vs
control
without
symptom
confid
interv
symptomfre
control
period
viru
detect
conclus
studi
support
import
rhinoviru
infect
communitydwel
elderli
person
wherea
asymptomat
elderli
person
also
harbor
pathogen
detect
pcr
thu
might
sourc
infect
environ
elderli
peopl
increas
suscept
respiratori
infect
relat
complic
averag
communitydwel
elderli
peopl
suffer
acut
respiratori
infect
per
year
medic
consult
hospit
infect
report
communitydwel
elderli
peopl
respect
winter
england
virus
play
crucial
role
acut
upper
respiratori
tract
infect
common
rhinovirus
coronavirus
influenzavirus
respiratori
syncyti
virus
howev
laboratori
diagnosi
acut
respiratori
infect
symptomat
elderli
peopl
far
focuss
institution
elderli
person
patient
report
medic
consult
far
less
degre
communitydwel
elderli
person
besid
data
avail
presenc
respiratori
pathogen
asymptomat
elderli
person
asymptomat
peopl
subclin
infect
might
howev
transmit
pathogen
person
act
unrecogn
sourc
respiratori
infect
therefor
prospect
communitybas
studi
investig
presenc
known
respiratori
virus
elderli
person
without
symptom
acut
upper
respiratori
tract
infect
second
compar
clinic
characterist
person
suffer
acut
respiratori
infect
episod
posit
neg
virolog
laboratori
diagnosi
person
without
symptom
acut
respiratori
infect
hereaft
refer
case
control
recruit
octob
octob
intervent
trial
investig
effect
micronutri
supplement
acut
respiratori
infect
communitydwel
elderli
person
year
studi
period
diari
use
daili
particip
report
symptom
indic
acut
respiratori
infect
particip
request
report
onset
symptom
possibl
infect
studi
nurs
subject
identifi
case
hesh
respiratori
symptom
sudden
onset
rhinorrhoea
sneez
sore
throathoars
dri
cough
present
least
day
symptom
pattern
differ
usual
symptom
apart
check
telephon
studi
nurs
evalu
symptom
case
home
visit
case
report
symptom
within
day
studi
nurs
everi
case
maximum
five
case
per
week
select
virolog
assess
case
report
symptom
day
studi
nurs
exclud
virolog
assess
overcom
fals
neg
test
result
case
episod
ie
period
case
respiratori
symptom
preced
symptomfre
period
studi
period
incid
case
episod
report
case
total
case
episodesreport
caseswer
select
virolog
assess
case
episod
asymptomat
control
select
follow
particip
number
includ
case
control
rang
particip
number
case
lower
closest
elig
control
select
particip
number
count
back
number
particip
number
case
higher
closest
elig
control
select
count
forward
number
control
subject
without
symptom
respiratori
infect
within
time
window
week
week
symptomat
period
index
case
studi
nurs
check
absenc
symptom
time
recruit
control
diari
check
absenc
symptom
previou
eight
week
total
control
select
case
control
match
age
year
sex
live
hous
apart
chronic
obstruct
pulmonari
diseas
asthma
cancer
use
sever
immunosuppress
medic
afterward
exclud
origin
enrol
control
develop
symptom
median
durat
day
rang
six
exclud
control
serolog
test
neg
two
miss
pcr
two
time
rhinoviru
two
time
coronaviru
detect
eight
exclud
control
result
present
therefor
base
case
episod
control
period
studi
approv
medic
ethic
committe
wageningen
univers
netherland
written
inform
consent
obtain
particip
prior
studi
particip
fill
questionnair
concern
relev
subject
characterist
baselin
diari
use
daili
selfreport
symptom
indic
acut
respiratori
infect
apart
symptom
present
case
definit
rhinorrhoea
sneez
sore
throathoars
dri
cough
also
accompani
symptom
record
diari
symptom
lower
respiratori
tract
infect
sputum
product
wheez
pain
respir
system
symptom
feverselfassess
suppli
thermometermalais
headach
rigor
muscular
pain
perspir
symptom
tear
eye
pain
facial
sinus
ear
restrict
activ
stay
bed
abl
daili
activ
stay
home
episoderel
medic
includ
antibiot
use
medic
consult
hospit
studi
nurs
judg
home
visit
case
symptom
acut
respiratori
infect
case
match
control
acut
phase
serum
sampl
one
swab
nose
one
throat
taken
within
day
convalesc
serum
sampl
taken
within
week
onset
first
symptom
case
sampl
case
control
taken
day
exclud
season
differ
pcr
serolog
use
diagnos
infect
eight
common
respiratori
virus
mycoplasma
pneumonia
pneumonia
pcr
perform
virus
either
aspecif
serolog
avail
valid
pcr
test
avail
lab
infect
rhinoviru
enteroviru
coronaviru
respiratori
syncyti
viru
diagnos
pcr
serolog
perform
virus
either
pcr
avail
nucleic
acid
extract
method
chang
dna
isol
case
pneumonia
infect
influenzaviru
b
parainfluenzaviru
adenoviru
pneumonia
diagnos
serolog
swab
nose
throat
hereaft
refer
nosethroat
sampl
place
togeth
hank
balanc
salt
solut
contain
gelatin
lactalbumin
yeast
antibiot
upon
receipt
nose
throat
sampl
laboratori
swab
twirl
transport
medium
remov
aliquot
sampl
use
nucleic
acid
extract
use
high
pure
rna
isol
kit
boehring
mannheim
germani
five
microlit
elut
rna
prepar
use
singletub
rtpcr
follow
nestedpcr
use
primer
pair
describ
previous
rhinoenteroviru
anoth
extract
rna
use
singl
singletub
rtpcr
follow
nestedpcr
use
primer
pair
describ
previous
respiratori
syncyti
viru
rsv
coronaviru
multiplex
format
rna
isol
procedur
pcrmethod
rsv
detect
sensit
rsv
one
viru
particl
rsv
b
viru
particl
viru
particl
count
determin
quantit
em
advanc
biotechnolog
incorpor
columbia
md
posit
control
cultur
use
pcr
test
respect
virus
prevent
carryov
contamin
within
laboratori
prepar
patient
sampl
pcr
mixtur
perform
safeti
hood
separ
dedic
posit
pressur
laboratori
check
carryov
contamin
sampl
amplicon
contamin
procedur
neg
control
consist
transport
medium
includ
everi
fifth
patient
sampl
subject
posit
pcr
result
consid
infect
known
viru
interpret
laboratoryconfirm
infect
pair
sera
case
control
analyz
igg
antibodi
influenzaviru
b
adenoviru
pneumonia
parainfluenzaviru
iga
antibodi
combin
three
antigen
one
assay
detect
analys
perform
use
commerci
avail
elisa
serion
immunodiagnostica
gmbh
germani
quantit
result
express
unitsmillilit
calcul
use
lotspecif
standard
curv
calcul
tabl
suppli
test
kit
result
interpret
neg
indetermin
posit
accord
manufactur
instruct
case
indetermin
result
parainfluenza
iga
assay
pair
sera
detect
total
antibodi
separ
parainfluenza
antigen
repeat
complement
fixat
assay
cfa
use
commerci
avail
parainfluenza
antigen
virion
ruschlikon
switzerland
elisa
chang
neg
posit
result
cfa
fourfold
rise
antibodi
titer
pair
sera
interpret
laboratoryconfirm
respiratori
infect
data
analysi
concern
virolog
includ
pneumonia
assess
perform
case
episod
control
period
differ
distribut
continu
data
ie
age
selfperceiv
health
ill
durat
compar
independ
sampl
student
ttest
ill
durat
normal
distribut
log
transform
obtain
normal
chisquar
test
fisher
exact
test
use
test
correl
discret
variabl
ie
sex
influenza
vaccin
smoke
habit
allergi
share
apart
presenc
microorgan
symptom
lower
respiratori
tract
infect
system
symptom
restrict
activ
fever
medic
consult
hospit
episoderel
medic
episoderel
antibiot
use
fisher
exact
test
use
calcul
odd
ratio
demonstr
viru
case
symptom
acut
respiratori
infect
vs
control
without
symptom
infect
alpha
taken
analys
match
procedur
sex
age
result
wellbalanc
group
case
control
respect
relev
variabl
tabl
micronutri
supplement
relat
intervent
trial
also
similar
case
control
symptomat
case
case
episod
respiratori
infect
virolog
includ
pneumonia
test
perform
case
episod
least
one
microorgan
demonstr
wherea
two
two
differ
microorgan
demonstr
case
episod
none
appli
test
posit
case
two
case
episod
includ
seven
mention
case
test
result
differ
ie
differ
pathogen
neg
one
posit
virolog
episod
two
case
episod
neg
virolog
one
case
episod
rhinoviru
detect
common
virus
demonstr
rhinovirus
coronavirus
follow
influenzavirus
enterovirus
parainfluenzavirus
pneumonia
respiratori
syncyti
viru
adenoviru
detect
three
seven
case
diagnos
influenzaviru
infect
vaccin
influenza
none
titer
rise
influenzaviru
infect
diagnos
relat
vaccin
month
pass
vaccin
diagnosi
influenzaviru
infect
presenc
rhinoviru
infect
almost
five
time
higher
compar
influenzaviru
infect
communitydwel
elderli
popul
tabl
control
period
viru
demonstr
ie
two
time
rhinoviru
two
time
coronaviru
two
four
control
posit
virolog
never
show
symptom
respiratori
infect
studi
period
two
remain
control
posit
virolog
symptom
least
month
month
sampl
collect
respect
overal
odd
ratio
demonstr
viru
pneumonia
case
symptom
vs
control
without
symptom
acut
respiratori
infect
confid
interv
despit
small
number
n
significantli
influenzaviru
infect
identifi
symptomat
period
winter
octobermarch
compar
summer
p
enterovirus
parainfluenzavirus
pneumonia
detect
summer
aprilseptemb
clinic
characterist
person
suffer
acut
respiratori
infect
episod
posit
neg
virolog
laboratori
diagnosi
describ
tabl
influenzaviru
infect
associ
significantli
longer
ill
durat
system
symptom
infect
posit
neg
virolog
restrict
activ
presenc
fever
medic
consult
antibiot
use
also
frequent
report
influenzaviru
infect
although
significantli
differ
infect
posit
neg
virolog
studi
show
subclin
respiratori
infect
occur
minor
part
asymptomat
elderli
person
besid
show
import
rhinoviru
infect
communitydwel
elderli
peopl
high
frequenc
knowledg
first
studi
investig
sever
common
respiratori
pathogen
communitydwel
elderli
person
without
symptom
acut
respiratori
infect
far
two
studi
report
microbiolog
evid
respiratori
infect
communitydwel
healthi
subject
without
symptom
infect
one
studi
focuss
detect
rhinovirus
enterovirus
pcr
children
adult
asymptomat
children
adult
respect
virolog
assess
posit
although
johnston
et
al
test
rhinovirus
enterovirus
frequenc
subclin
respiratori
infect
healthi
adult
similar
observ
older
popul
preliminari
result
dutch
studi
perform
person
consult
gener
practition
sign
symptom
acut
respiratori
infect
show
posit
virolog
assess
control
percentag
higher
observ
studi
howev
studi
popul
exist
particip
age
categori
includ
babi
children
show
johnston
et
al
percentag
asymptomat
person
posit
virolog
assess
clearli
higher
children
might
explain
discrep
common
viral
pathogen
demonstr
symptomat
period
children
adult
institution
elderli
patient
patient
medic
consult
communitydwel
elderli
person
rhinovirus
coronavirus
influenzaviru
b
rsv
line
result
frequenc
common
virus
vari
differ
subpopul
correspond
one
previous
perform
communitybas
elderli
studi
also
show
rhinoviru
infect
highli
preval
caus
great
overal
diseas
burden
popul
correspond
result
nicholson
et
al
communitydwel
elderli
person
contrast
studi
frail
elderli
person
live
institution
studi
gener
practitionerbas
set
also
observ
influenzaviru
infect
rsv
infect
seem
occur
less
frequent
freeliv
elderli
peopl
sever
morbid
caus
virus
influenzaviru
rsv
correspond
result
influenzaviru
infect
might
explain
higher
frequenc
rsv
influenzaviru
infect
demonstr
studi
gener
practitionerbas
institution
set
total
patient
influenzaviru
infect
vaccin
influenza
might
indic
need
prevent
vaccin
elderli
person
agreement
studi
institution
communitydwel
elderli
subject
found
infect
parainfluenzaviru
enteroviru
adenoviru
pneumonia
minor
import
caus
acut
respiratori
infect
elderli
person
obtain
microbiolog
diagnosi
case
episod
diagnost
deficit
rel
low
studi
microorgan
demonstr
maximum
case
episod
partli
new
unknown
virus
bacteria
atyp
microorgan
pneumonia
may
respons
clinic
possibl
addit
subclin
infect
neg
microbiolog
bacteri
atyp
viral
microorgan
adult
patient
consult
respiratori
infect
shown
patient
respect
also
chlamydia
speci
report
caus
acut
respiratori
infect
communitydwel
elderli
person
although
proport
bacteri
infect
report
rare
adult
patient
common
cold
besid
chlamydia
infect
occur
communitydwel
elderli
peopl
mainli
analyz
patient
copd
asthma
exclud
patient
howev
exclud
part
diagnost
deficit
studi
might
explain
bacteri
atyp
microorgan
littl
known
time
period
infect
pcrbase
test
posit
issu
especi
crucial
interpret
pcr
posit
result
nosethroat
sampl
obtain
subject
without
symptom
respiratori
infect
andeweg
et
al
demonstr
rhinovirus
longer
detect
pcr
patient
recov
diseas
studi
case
control
follow
day
day
use
selfreport
diari
system
therefor
possibl
includ
control
symptom
month
month
sampl
thu
unlik
control
viru
detect
postinfecti
incub
period
symptomat
infect
moreov
nosethroat
sampl
four
eight
exclud
control
respiratori
viru
detect
control
appar
incub
period
detect
rhinoviru
enteroviru
rsv
coronaviru
infect
pcr
method
use
wide
accept
although
pcrbase
test
highli
sensit
specif
fals
posit
due
contamin
neg
sampl
pcr
product
laboratori
might
occur
howev
given
strict
condit
pcr
perform
unlik
neg
control
includ
fifth
test
sampl
pcrneg
sampl
indic
contamin
effect
prevent
underreport
could
occur
case
admit
hospit
acut
respiratori
infect
none
case
report
admit
hospit
acut
respiratori
infect
complic
underreport
hospit
issu
studi
subject
particip
studi
recruit
intervent
trial
studi
effect
micronutri
supplement
acut
respiratori
infect
random
select
particip
doubleblind
intervent
trial
result
similar
distribut
supplement
case
control
signific
correl
posit
microbiolog
test
type
supplement
therefor
confound
supplement
like
neglig
studi
conclus
rhinoviru
infect
caus
substanti
morbid
among
communitydwel
elderli
person
high
preval
popul
also
although
definit
respiratori
microorgan
demonstr
among
person
symptom
acut
respiratori
infect
asymptomat
elderli
person
also
harbor
respiratori
pathogen
thu
might
sourc
infect
environ
